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Introduction

Abstract

In squamous cell carcinoma of the esophagus, earlier treatment strategies of either radiotherapy alone or
surgery alone (Earlam and Cunha-Melo, 1980a,b) have
given way to multimodal forms of treatment in an attempt to improve the otherwise gloomy prognosis.
At the Department of Oncology, University Hospital, Lund, a phase II trial was carried out during the
period 1984-1988, in which patients with esophageal
squamous cell carcinoma were pretreated with three
courses of cytostatics (cisplatin + 5-fluorouracil) followed by radiotherapy and surgery. Not only was the
treatment well tolerated but, as compared with earlier
published results, the outcome manifested improvement
both in terms of palliation and survival rates (Mercke et
al., 1991). In order to intensify treatment, the preoperative radiotherapy was given together with the third
course of chemotherapy. The rationale for this derived
from findings in an earlier series of animal experiments
where rabbits underwent cisplatin treatment and irradiation of the superior mediastinum, and where damage,
proliferation and reparative effects in normal tissue were
investigated, recovery being found to be better and more
rapid in those parts of the trachea and esophagus exposed to the combined treatment than in unexposed areas
(Albertsson et al., 1992).
In the present study, scanning electron microscopy (SEM) was performed on a number of patients consecutively treated for esophageal cancer at our department in order to study the effect of treatment both on the
tumor and the surrounding mucosa. For comparison, we
examined specimens from five patients treated with primary surgery alone. The aim of the study was to assess
damage and proliferation in tumor and normal mucosa!
tissue, and if possible ascertain whether any correlation
existed between treatment and clinicopathological outcome variables.

Specimens taken at surgery from 15 patients with
carcinoma of the esophagus were examined with scanning electron microscopy.
Nine patients were treated
with chemotherapy (cisplatin + 5-fluorouracil), surgery
and radiotherapy; one received preoperative radiotherapy
only; and the remaining five primary surgery only.
Scanning electron microscopy was performed on specimens of both tumor tissue and the mucosa at least 5 cm
from the tumor. In adjacent non-tumor tissue, damage
due to treatment was observed in the form of changes in
microridges and increased cell loss. In tumor tissue, the
degree of damage was correlated to tumor response to
treatment.
For patients with no residual tumor after
treatment, the ultrastructure was normalized with a low
tumor score, while for patients with residual tumor, the
score was high.
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Materials and Methods
The clinical characteristics of the 15 patients with
esophageal cancer, either squamous cell carcinoma (n =
13) or adenocarcinoma (n = 2), are shown in Table 1.
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The patients were divided into three groups, according
to their treatment:
1) Control group (n = 5, 1 female, 4 males),
aged 61-86 years who underwent primary surgery without any pretreatment.
2) Standard treatment group (n = 7, all males),
aged 60-68 years, treated with three cycles of chemotherapy and preoperative radiotherapy (24 Gy).
Group 2a) Standard treatment, no residual tumor.
Group 2b) Standard treatment, residual tumor.
3) Pretreated group (n = 3, 2 females, 1 male),
aged 66- 76 years, whose treatment deviated from that of
the standard treatment group for one reason or another.

resected at surgery.
If histopathologic
examination
showed the presence of viable malignant cells, the total
absorbed dose was 40 Gy, otherwise only 24 Gy (i.e.,
only the preoperative radiotherapy was given). In the
case of tumors below the tracheal carina, AP-PA (anteroposterior-posteroanterior)
fields were used preoperatively (target volumes I and II); and postoperatively a 3field technique with one dorsal and two oblique portals
was used for target volume I and AP-PA fields for target
volume II with a specified dose of 40 Gy. The targetabsorbed dose was specified according to minimum absorbed dose. Daily fractionated radiation was given with
a target dose of 2. 0 Gy.

Sampling

Surgery Surgery included laparotomy for inspection of liver and celiac nodes, the latter being resected
if cancer was suspected. The stomach and the duodenum
were mobilized and pyloromyotomy performed.
The
esophagus was resected through a right-sided thoracotomy, the stomach being pulled up into the chest and an
anastomosis performed between the fundus and the proximal esophagus.

Specimens for SEM were taken in conjunction
with surgery. One specimen was taken from the tumor
area (TA); if no residual tumor was visible at surgery,
a specimen was taken from the area initially considered
to be tumor-involved.
In addition, for control purposes,
a non-tumor area (NTA) specimen was taken from the
esophageal mucosa at least 5 cm from the visible border
of the tumor area.

Specimen preparation for SEM
Specimens for SEM were fixed in 2.5% glutaraldehyde (in 0.15 M cacodylate buffer, pH = 7.3) for 12
hours, followed by postfixation in 1 % osmium tetroxide
in 0.15 M cacodylate buffer for two hours. After dehydration in a graded ethanol series and critical point
drying, the specimens were sputter-coated with gold and
examined in a Philips 515 SEM operated at 20 kV.
Scoring system
For evaluation of the specimens, the following 5point scoring system was used:
Score 0: Normal epithelium.
Score 1: Membrane damage with edema and exudate.
Score 2: Damaged microridges manifesting the 'farcimen phenomenon' (i.e., broken up into short
segments linked like a string of sausages),
nodules (knobs),
fluid-containing
vesicles
(blebs) and other protrusions.
Score 3: Ulceration, microridges rudimentary or lost.
Score 4: Manifest destruction, no normal surface structures identifiable.

Treatment
The treatment protocol consisted of three courses
of chemotherapy followed by radiotherapy and surgery:

Chemotherapy Chemotherapy consisted of cisplatin [90-120 mg/m 2 BSA (body surface area)] on day
1, and 5-fluorouracil (5-FU 1000 mg/m 2 BSA) daily in
continuous infusion on days 1-5. Before cisplatin administration, the patients were prehydrated with 1000 ml
0.9% saline given as a 2-hour infusion. Cisplatin was
dissolved in 2000 ml 0.9% saline and given together
with 500 ml 15% mannitol as an intravenous infusion
over four hours.
Uresis was measured every fourth
hour, diuretics being given if it was less than 400 ml for
the 4-hour period. Treatment with 5-FU started immediately after completion of the cisplatin infusion, the 5-FU
being dissolved in 2000 ml 0.9% saline and given as
continuous 24-hour infusion for five consecutive days.
Radiotherapy For patients with out metastasis, an
absorbed dose of 64 Gy to the esophageal tumor (target
volume I) was planned in two series as pre- and postoperative radiotherapy.
In all cases, radiation therapy was
given with 6 MY or 8 MY photons, using a linear accelerator. Target volume I was defined as the tumor demonstrated at chest radiography or CT (computerized tomography).
For tumors at or above the tracheal carina,
the caudal border of target volume I was set 5 cm below
the lower extension of the tumor, whereas its cranial
border included the supraclavicular nodes. For these upper tumors, a 3-field approach was used both pre- and
postoperatively.
For tumors, the bulk of which was located below the level of the carina, the cranial border
was set to include 5 cm of radiographically
uninvolved
esophagus, whereas the celiac lymph nodes were included in target volume II, and defined the caudal border of
target volume I.
Any affected nodes in the celiac region were

From each specimen, at least ten different areas
were evaluated by five independent observers.
Corresponding tumor and non-tumor specimens were rated according to this scoring system, yielding a mean case
score and mean group score (see Fig. 8, for results).

Results
Group 1. Control group
control
(Table
regular
clearly
face of
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SEM of esophageal mucosa specimens from the
group of patients undergoing no pretreatment
1) showed polygonal cell flakes, arranged in
patterns (Figures la-c).
Cell borders were
identifiable, and did not protrude from the surthe mucosa. Some cell loss was usually seen,

Electron microscopy of human esophageal mucosa

Table 1. Clinical data from 15 patients with esophageal carcinoma.
Age

Sex

Group 1
75
1
2
86
82
3

M
F

62
61

No.

4
5

Level Pathol

M

A

M
M

Low

A

7
11
5

s

4.0

1.37

2a, 2b, 2c
3a, 3b, 3c

1.5

1.12

4a-4e

5a, 5b
6a, 6b

5
24

Gy
Gy
Gy
Gy
Gy

9
29
40
12
26

3.0

2.0

1 (cht) + RT 40 Gy
1 (cht) + RT 24 Gy
RT 40 Gy

16
7
4

3.5

2.0

treatment, residual tumor)
Mid
3 (cht) +
s
Mid
3 (cht) +
s
Low
3 (cht) +
s
Up
3 (cht) +
s
Low
3 (cht) +
s

Group 3
13
66
14
68
76
15

F
F
M

Low
Low
Mid

s
s
s

Figures

la, lb, le

treatment, no residual tumor)
Low
3 (cht) + RT 24 Gy
s
Low
3 (cht) + RT 24 Gy
s

M
M
M
M
M

s

Score SEM
Tumor area
Non-tumor area

5
7

65
60
60
68
61

8
9
10
11
12

Survival
months

s
s

Low
Low
Low

Group 2a (standard
64
M
6
62
7
M
Group 2b (standard

Pretreatment

RT
RT
RT
RT
RT

24
24
24
24
24

7a, 7b

cht = chemotherapy;
RT = radiotherapy.
= Squamous cell carcinoma;
A= Adenocarcinoma;
------ - - -- - --- - - - -- - - - - - - - - - -- - - - -- - -- - - - - --- - - - --- - -- -- - - - - - - - - -- - -- - - - - - - - -- - - - - - - - --- - - - - - - - - - - - - - - ---

often occurring in flakes of groups of cells, but sometimes of whole single cells. Cell surfaces were covered
with microridges, often parallel to each other but sometimes in whorled or convoluted configurations, the patterns being homogeneous within a given cell but often
varying from one cell to another. The microridges usually manifested small, barely discernible nodular irregularities (Fig. lb).
Occasionally the microridges appeared to be swollen, manifesting the 'farcimen phenomenon' (Fig. le). Sometimes the nodular irregularities
appeared to be distended, like small bullae, connected to
the original microridges by fine 'stems'; and sometimes
they had the form of a broad-based protrusions (Fig.
2c). Occasionally microridges covered the greater part
of the cell surface in the form of protrusions (Fig. 2b),
and sometimes they were grouped in nidulate configurations (Fig. 2a). Two of the patients in this group were
found to have adenocarcinoma. The TA specimen of one
of the two patients with adenocarcinoma manifested polygonal cells outlined with short, stubby microvilli (Fig.
3a). Occasionally a closed packed rim of microvilli
could be seen surrounding a central area of mucus. In
another area, the cells manifested marked bulging and
their surfaces were covered with microvilli (Fig. 3b).
For comparison, Fig. 3c shows the normal squamous
epithelium in an NT A specimen from the same patient.

Group 2a (Standard treatment, patients with no
residual tumor after preoperative treatment, n = 2)
No malignant cells were identifiable within the
original tumor area, specimens being similar to those
from normal epithelium (NTA), though some differences
could be observed. In TA specimens, cells were rounded and plaque-like, lying loosely on the surface (Fig.
4a), without the interconnections seen between normal
cells. In some areas the cells were swollen with edema
and exudate (Fig. 4b); in others, the microridges were
arranged in irregular configurations, being sometimes
very closely packed, and manifesting the 'farcimen
phenomenon' (Fig. 4c). Intercellular spaces took the
form of cracks and fissures. No microorganisms were
found. Figures 4d and 4e from the same patient present
micrographs from non-tumor area. The cell borders are
clearly defined (Fig. 4d) and microridges are arranged
in regular patterns.
Group 2b (Standard treatment, patients with residual
tumor)
TA specimens manifested pronounced heterogeneity in cell surface morphology. In some areas, no normal microridge patterns could be seen; some areas were
completely denuded of microridges, and in other areas,
they were present only in rudimentary form (Fig. 5a).
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Figure 1 (facing page, left). Scanning electron micrographs of a non-tumor area (NT A) specimen from a
group 1 (non-pretreated) patient (no. 1) with squamous
cell carcinoma, showing: a) wrinkled epithelium, and
exudate (arrow); b) mucus-containing bulges (arrow, B)
and knobs from microridges (arrow, Kn); c) swollen
microridges manifesting the 'farcimen phenomenon'
(arrow) and cell borders raised in relief.
Figure 2 (facing page, right). Micro graphs of an NT A
specimen from a group 1 (non-pretreated) patient (no. 3)
with adenocarcinoma, showing: a) clustered protrusions
contained within a nidulate arrangement of microridges;
b) protrusions; and c) central area of Fig. 2b, at a
higher magnification.
Figure 3 (at right). Micrographs of specimens from a
group 1 (non-pretreated) patient (no. 3) with adenocarcinoma: a) TA specimen showing cells with borders covered with microvilli; b) TA specimen, showing singular
bulging cells, the entire surface of which is covered with
microvilli; c) NTA specimen, showing swollen cell borders and microridges in regular arrangements.

In the NT A specimen, cell borders were distinct and

raised in relief, the cell surface manifesting regular patterns of microridges (Fig. Sb). Microridges manifested
great morphological variation from one area of a given
cell to another, and there was no sign of the regular surface pattern seen in normal cells. Normal cell borders
were absent, intercellular spaces taking the form of
cracks and fissures. In some cases, abnormalities of cell
surface morphology were manifested, with no normal
features remaining (cf. Figures 6a and 6b). In TA
specimens, cells manifested gross superficial destruction, with filamentous processes extending across the
surface (Fig. 6a); cell borders could not be discerned.
In NTA specimens, the surface was covered with short,
stubby microridges of a nodular appearance (Fig. 6b),
which could be verified by transmission electron microscopy (TEM).
Group 3
For patient number 15, given preoperative radiotherapy (40 Gy) but no chemotherapy, the TA specimen
manifested gross superficial destruction, and no normal
cell structures could be discerned (Fig. 7a). His NTA
specimen showed slight treatment damage, manifesting
edema, exudate and a somewhat wrinkled epithelium
(Fig. 7b).
From the scoring results shown in Fig. 8, it can
be seen that for group 1 (i.e., patients who underwent
surgery only) the NT A score was just over 1, and the
TA score 4. For patients with no residual tumor after
preoperative treatment (n = 2), the TA score was 1.5
and the NT A score 1. 1. For patients with residual
tumor at surgery, the NT A score (2. 0) was higher than
in the other two groups, and the TA score was markedly
higher, 3.0 in group 2b and 3.5 in group 3.
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Figure 4. Micrographs of specimens from a group 2a (pretreated) patient (no. 7) with no residual tumor at surgery: a) TA
specimen showing plaque-like epithelial cells in singular formations; b) TA specimen showing swollen cells with disrupted microridges, edema and exudate (arrow), the microridge abnormality presumably being attributable to treatment; c) an area from
Fig. 3b at a higher magnification, showing densely packed microridges with the farcimen phenomenon (arrows), and microridges
in irregular patterns; d and e) NTA specimen showing normal
microridges in regular patterns and clearly defined cell borders.

Figures S and 6 (on facing page). Micro graphs of specimens
from group 2b (pretreated) patients (no. 10, Figure S; and no.
11, Figure 6) with residual tumor at surgery: Fig. Sa) TA
specimen showing cells with microridges almost absent or only
present in rudimentary form (arrows); Fig. Sb) NTA specimen
showing slightly damaged microridges, and cell borders with
exudate (arrow); Fig. 6a) TA specimen, showing heavy surface
destruction; and Fig. 6b) NTA specimen, showing the surface
covered with short, stubby microridges.
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Figure 7. Micrographs of specimens from a group 3 (non-standard pretreatment) patient (no. 15) with residual tumor at
surgery: a) TA specimen, showing heavy surface destruction; b) NT A specimen, showing wrinkled epithelium, and exudate.
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Score mean value

4-

Control

Pretreatment
program completed

Deviation from
pretreatment program

3

2

1

0

Group 1

Group 2a

Group 2b

Group 3

Figure 8. Mean scores for tumor area (hatched) and non tumor area (unhatched) specimens in groups 1, 2 and 3.
Discussion

membrane that apparently developed, becoming distended either like small balloons and attached to the microridges by stem-like processes, or in the form of a broad
based protrusions arranged in structured groups or covering a portion of the surface area (Figures 2a-c). Although at first glance it might seen reasonable to interpret these changes in microridge morphology as damage
attributable to treatment (e.g., chemotherapy or radiotherapy), they were also seen in untreated cases and may
well constitute a non-specific degenerative process
associated with any of a variety of factors.
The specimen shown in Fig. 2 is from the esophageal mucosa of an 82 year old man with adenocarcinoma
of the esophagus who underwent primary surgery only
(i.e., no pretreatment with chemotherapy or radiotherapy); in this case, the microridge degeneration may constitute, wholly or partly, an expression of the normal
ageing process. Moreover, as patients treated for esophagus cancer commonly manifest a weight loss of 5-15 kg
(11-33 lbs) at diagnosis, and often loose more weight
during treatment, it is not impossible that this weight
loss and dehydration also affect the esophageal mucosa,
perhaps explaining the wrinkled superficial appearance.
Ackerman et al. (1976) reported that the superficial microridges seen in SEM correlate well with the
short cytoplasmic processes of superficial mucosa! cells
seen in TEM. The microridges are believed to be of
functional importance in maintaining epithelial integrity,
cellular contact being enhanced by interdigitation.
An
early observable change is that the microridges swell,
increasing in diameter, and manifesting what we have
termed the 'farcimen phenomenon' (i.e., the microridge
is broken up into short segments, resembling a string of
sausages). A similar phenomenon is seen in very small
blood vessels exposed to radiation, and is said to be due
to the swelling of endothelial cells. Microridges have no

It has been a time-honored axiom in cancer therapy that the two principal treatment modalities, chemotherapy and radiotherapy, should not be given simultaneously but staggered to avoid unacceptable high toxicity
in normal tissue. However, in squamous cell carcinoma
of the esophagus, earlier treatment strategies of either
radiotherapy alone or surgery alone (Earlam and CunhaMelo, 1980a,b) have given way to multimodal forms of
treatment comprising chemotherapy, radiotherapy and
surgery (Launois et al., 1981; EORTC, 1985; Kelsen
1985; Carey et al., 1986; Popp et al., 1986; Leichman
et al., 1987; Hambraeus et al., 1988; Forastiere et al.,
1990; Herskovic et al., 1992), an approach introduced
with a view to improving both local control and the otherwise gloomy prognosis associated with this disease.
The recently reported treatment of esophageal
cancer with three cycles of chemotherapy combined with
radiotherapy and surgery has yielded promising results
(Mercke et al., 1991). In the present study, specimens
from 15 patients were examined by SEM to obtain further information. Specimens from five of the patients,
who had undergone surgery only (without pretreatment),
were selected for use as controls; however, their NT A
specimens were not found to be completely normal
according to previously published morphological data
(Ackerman et al., 1976; Robinson et al., 1981). In
those studies, normal esophageal mucosa is described as
a flat surface overlaid with polygonal epithelial cells and
regular patterns of microridges.
In the present patients, the surface adjacent to the
tumor area was wrinkled or folded, and the microridges
were not completely normal but manifested protrusions
of various kinds and sizes. A fairly common finding
was the presence of small nodular irregularities of the
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EORTC. (1985). Preoperative radiotherapy for
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(1981). Preoperative radiotherapy for carcinoma of the
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PB, Steiger Z, Tapazoglou E, Rosenberg JC, Arbulu A,
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connection to endothelial cells, and it is not known
whether there is any cytoplasmic content. However,
they form abundant connections (desmosomes) with
overlying or underlying cell layers.
In those group 2a cases, where no residual tumor
was found at surgery (n = 2), the esophageal mucosa in
the original tumor area was normalized, as reflected in
the mean scores for these patients (Fig. 8) which were
very close to the NT A scores for group 1 patients who
underwent surgery only (i.e., no chemotherapy or radiotherapy pretreatment).
All the normal structures can be identified in TA
specimens (Figures 4a-c). An abnormal finding was that
of loose cells on the cell surface, which may be attributable to an effect of the treatment on desmosomes, an issue that we shall be investigating in further studies using
TEM.
Group 2b patients, who had undergone pretreatment but manifested residual tumor at surgery (Figures
Sa Sb, 6a and 6b), had higher mean scores both in TA
and NT A specimens (Fig. 8). Although this finding is
striking, it should be borne in mind that the series is too
small to allow any firm conclusions to be drawn, other
than that perhaps group 2b patients constitute worse
cases generally, something that equally applies to group
3 patients (Figures 7a and 7b).
Concerning the abnormal morphology of tumor
cells, with microridges absent or only present in rudimentary form, the presence of poorly defined microridges has previously been reported both in reflux esophagitis (Dilly and Mallinson, 1975) and in preneoplastic
and neoplastic lesions (Williams et al., 1973). Moreover, both the reduction in the number of microridges
and their less regular arrangement, as seen on malignant
esophageal cells in the present study, have been described previously and interpreted as possibly due to the
rapid growth and turnover of malignant cells (Siew and
Goldstein, 1981). In the present study, no correlation
was found between tumor score and survival.
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columnar?
Authors: Yes, the findings were similar in the two
cases with adenocarcinoma and I find your interpretation
of the micrographs interesting and absolutely right.

S. Siew: You state that in cases with no visible residual
tumor, specimens were taken from the area initially considered to be tumor involved. By what means had such
areas been identified to have been involved prior to
therapy?
Authors: All patients were thoroughly investigated and
pretherapy staging was based on clinical history and examination, barium radiography of esophagus, esophagoscopy, chest radiography, CT of thorax and upper abdomen, blood count and serum tests of liver function. All
these examinations were repeated after chemotherapy
and radiotherapy for evaluation of response.

S. Siew: As Barrett's esophagus is an important predisposing factor of esophageal carcinoma, did you see evidence of that in your cases?
Authors: Barrett's esophagus is an important predisposing factor only for adenocarcinoma and we did have two
cases of adenocarcinoma in this study; we did find evidence of Barrett's esophagus in one of these cases.
S. Siew: Figure 7a illustrates the SEM findings in a
patient who had residual tumor after one course of radiotherapy.
Are you able to differentiate the degree of
damage inflicted by radiotherapy in the production of the
heavy surface destruction?
Authors: Unfortunately we could not differentiate the
damage. However, the exudation on the surface and the
fibrin-like network could be associated to radiation
damage.

S. Siew: Did you examine the tissues by means of light
microscopy? If so, what was the correlation between the
histopathologic and scanning electron microscopic findings? More particularly, in the 2 cases with no visible
gross tumor, was there evidence of tumor on microscopic examination?
Authors: Immediately after surgery, all the tissues were
examined with light microscopy, and also later on with
TEM, results of which will be presented at a later date.
In the 2 cases with no visible gross tumor, there was no
evidence of tumor on light microscopic examination.

M.J.A. Cornelissen: Since you mention in your Introduction that the aim of the study is to assess proliferation, would it not be appropriate to have an estimation
of proliferation capacity after treatment by using pro! if eration markers. Please comment and give some suggestions.
Authors: You are absolutely correct. In future, we are
planning to investigate the proliferation capacity for the
tumors with BuDR before, and also after, treatment.

S. Siew: You have shown that there was no correlation
between the tumor score and survival (Table 1). However, other factors have to be taken into consideration
such as the fact that esophageal tumors often spread beneath the mucosa. In such cases, the overlying mucosa
would have a spuriously normal appearing surface. Further, depth of invasion and metastasis, regional and
distant, determine the length of survival.
Authors: Your are absolutely correct and for this reason, all patients were thoroughly examined (see answer
to your first question above). Other investigations have
indicated that a complete response to chemotherapy is
strongly associated with a prolonged disease-free survival (Rooney et al., 1985; Al Kourainy et al., 1987;
Jacobs et al., 1987; Thomas et al., 1988). Unfortunately
in our study, the group of patients (n = 2) with no residual tumor after treatment died in intercurrent deaths.
One of the patients died after five months in pulmonary
embolism and autopsy showed no tumor. Also the other
patient with no residual tumor after pretreatment, died
in intercurrent death and again autopsy showed no residual tumor.
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S. Siew: There were 2 cases of adenocarcinoma.
Did
they show similar findings? Your micrographs (Figures
2a-c and 3a-c) are from one and the same case: Figures
2a-c and 3c being of non-tumor affected tissue and Figures 3a and 3b from the tumor. Do you not consider
that the appearance of Figures 3a and 3b, with the presence of microvilli and "bulging" cells, is in keeping with
that of a poorly differentiated adenocarcinoma and that
the bulging of the cells is due to the fact that they are
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